Aman Verma

Internal Medicine
701 Park Ave
Minneapolis, MN 55415

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Hyperleukocytosis increases risk of fatal hyperkalemia with new ibrutinib/venetoclax regimen for refractory mantle cell lymphoma.

Hyperleukocytosis increases risk of fatal hyperkalemia with new ibrutinib/venetoclax regimen for refractory mantle cell lymphoma.

Journal: Journal of chemotherapy (Florence, Italy)
Published: November 19, 2019
Showing 1-1 of 1

Last Updated: 09/26/2026